A telomerase component is defective in the human disease dyskeratosis congenita

[1]  R. Reddel,et al.  Telomere maintenance mechanisms and cellular immortalization. , 1999, Current opinion in genetics & development.

[2]  Jeffrey B. Cheng,et al.  A Box H/ACA Small Nucleolar RNA-Like Domain at the Human Telomerase RNA 3′ End , 1999, Molecular and Cellular Biology.

[3]  M. Mann,et al.  Cbf5p, a potential pseudouridine synthase, and Nhp2p, a putative RNA-binding protein, are present together with Gar1p in all H BOX/ACA-motif snoRNPs and constitute a common bipartite structure. , 1998, RNA.

[4]  S. Klauck,et al.  X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions , 1998, Nature Genetics.

[5]  L. Luzzatto,et al.  Dyskeratosis and ribosomal rebellion , 1998, Nature Genetics.

[6]  V. Lundblad,et al.  The telomerase reverse transcriptase: components and regulation. , 1998, Genes & development.

[7]  D. Tollervey,et al.  The box H + ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase. , 1998, Genes & development.

[8]  T. Ide,et al.  Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein – Barr virus , 1997, Oncogene.

[9]  D. Tollervey,et al.  Function and synthesis of small nucleolar RNAs. , 1997, Current opinion in cell biology.

[10]  Tamás Kiss,et al.  Site-Specific Pseudouridine Formation in Preribosomal RNA Is Guided by Small Nucleolar RNAs , 1997, Cell.

[11]  J. Ni,et al.  Small Nucleolar RNAs Direct Site-Specific Synthesis of Pseudouridine in Ribosomal RNA , 1997, Cell.

[12]  I. Dokal.  Dyskeratosis congenita: an inherited bone marrow failure syndrome , 1996, British journal of haematology.

[13]  et al.,et al.  The RNA component of human telomerase , 1995, Science.

[14]  R. Reddel,et al.  Telomere elongation in immortal human cells without detectable telomerase activity. , 1995, The EMBO journal.

[15]  C. Greider,et al.  Developmental and tissue-specific regulation of mouse telomerase and telomere length. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[17]  G. Blobel,et al.  NAP57, a mammalian nucleolar protein with a putative homolog in yeast and bacteria [published erratum appears in J Cell Biol 1998 Jan 26;140(2):447] , 1994, The Journal of cell biology.

[18]  C. Harley,et al.  Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes , 1994, Journal of virology.

[19]  J Ofengand,et al.  Four newly located pseudouridylate residues in Escherichia coli 23S ribosomal RNA are all at the peptidyltransferase center: analysis by the application of a new sequencing technique. , 1993, Biochemistry.

[20]  L. Luzzatto,et al.  Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. , 1992, Blood.

[21]  B. Alter,et al.  Dyskeratosis Congenita: Clinical and Genetic Heterogeneity Report of a New Case and Review of the Literature , 1992, The American journal of pediatric hematology/oncology.

[22]  T. Dexter,et al.  "Stem cell" origin of the hematopoietic defect in dyskeratosis congenita. , 1992, Blood.

[23]  Robin C. Allshire,et al.  Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.

[24]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[25]  E. Blackburn,et al.  In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs , 1990, Nature.

[26]  A. Trowbridge,et al.  Dyskeratosis congenita: clinical features and genetic aspects. Report of a family and review of the literature. , 1975, Journal of medical genetics.

[27]  A. Trowbridge,et al.  Dyskeratosis congenita: Hematologic evaluation of a sibship and review of the literature , 1977, American journal of hematology.